Atlas Trials

Ketamine Biomarker Validation

Clinical trial NCT07307768 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07307768
Sponsor
Soterix Medical
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Treatment Resistant Depression (TRD)
Start date
2025-12-20
Primary completion
2027-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.